CompletedNot Applicable

Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement

United States100 participantsStarted 2017-06-06

Plain-language summary

Most of the conduction abnormalities with TAVR are usually detected during the procedure or during the following days of observation. Little is known about the prevalence and timing of any conduction abnormalities that exist before (other than standard ECG) or after through long term cardiac monitoring.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age \> 18 and \<90 years old
✓. Able to provide informed consent
✓. Willing to follow up at Cleveland Clinic (per TAVR protocol)

Exclusion criteria

✕. Prior CIED (Pacemaker or defibrillator)
✕. Unable to provide consent
✕. Unable to follow up at Cleveland Clinic per TAVR protocol

What they're measuring

Need for Pacemaker post TAVR

Timeframe: 2 months prior to TAVR

Trial details

NCT IDNCT03180073

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12-23

View on ClinicalTrials.gov More Bradycardia trials